ZoomInfo vs Cognism Under an RIA's Marketing Rule Review

Consult with your firm's chief compliance officer or outside counsel before licensing either tool for advisor outreach; the specific do-not-call and marketing rule requirements that apply depend on your firm's registration status and how it structures recorded outreach. This guide covers what each platform does operationally, not a substitute for that review.

Once that review is done, the operational question becomes how much of the compliance burden the platform itself removes versus how much your team still has to manage manually before every campaign. Firms that skip this ordering, evaluating tools on sales fit first and looping in compliance only before launch, tend to discover late that a platform they already like does not fully cover their specific documentation needs.

Cognism scrubs contact lists against do-not-call registries automatically before outreach and documents a lawful basis for each contact, which reduces the manual screening work a compliance team would otherwise do campaign by campaign. For an RIA prospecting individual investors, where do-not-call exposure is highest, that automated documentation is often the deciding factor over raw data coverage.

The tradeoff is that automated screening still requires your firm to confirm the documentation actually satisfies your specific compliance program, not just assume it does because the vendor built the feature.

ZoomInfo is the stronger fit when growth comes from corporate retirement plan sponsors rather than individual investors, since the compliance profile is different: you are reaching a plan sponsor's benefits or HR lead, not an individual consumer covered by the same do-not-call rules. ZoomInfo's org records identify who inside the plan sponsor actually owns that decision, which is often buried a level or two below the executive team.

An advisory firm growing primarily through institutional and retirement plan channels may find registry screening less central to its risk profile than getting to the right internal owner quickly.

If your growth plan depends on prospecting individual investors directly, prioritize registry screening and documented consent first, which points toward Cognism. If your growth plan runs through corporate retirement plan sponsors, prioritize organizational data that identifies the plan sponsor's internal decision-maker, which points toward ZoomInfo.

Many advisory firms do both, prospecting individuals for wealth management while also pursuing plan sponsor relationships, and may need different tools or workflows for each motion rather than forcing one platform to cover both.

Before signing, have compliance review the specific documentation each platform produces and confirm it satisfies your firm's actual marketing rule program, not a generic claim in the vendor's sales materials. Ask for a sample of the consent or screening documentation directly, not just a description of the feature.

Only after that review is complete should sales leadership run a pilot focused on connect rates and meeting conversion. Roger, MeetMyCRO's AI CRO, can help structure that pilot once the compliance review has cleared either platform for use.

Ask your compliance team to check these items:

• Which do-not-call registries and consent records each platform documents, and whether a sample of that documentation satisfies your firm's marketing rule program.
• Whether the vendor's screening claims match your registration status and how your firm structures recorded outreach, rather than a generic line in sales materials.
• Whether your growth channel is individual investors or corporate retirement plan sponsors, since the compliance profile is different for each.
• Who owns the recurring review of screening and consent documentation after launch, and how often that review happens.

A screening and consent process that was compliant at signup can drift out of date as registries update and your firm's own program evolves, so a one-time review at contract signing is not enough on its own. Set a recurring review, tied to whatever cadence your compliance program already uses for other vendor oversight, rather than treating the initial sign-off as permanent.

Advisors should also know what to do if a prospect raises a concern about how they were contacted, since a documented process only helps if the team can actually produce the relevant record when asked. Build that retrieval step into onboarding for anyone using either platform, not just the initial compliance approval.

A firm that grows through referrals as well as direct prospecting should also confirm whether referred contacts fall under the same screening requirements as cold outreach, since the answer is not always obvious and depends on how the referral itself was generated. That distinction is worth raising with compliance directly rather than assuming a referral is automatically exempt.